SG11201901983PA - Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrrole - Google Patents
Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrroleInfo
- Publication number
- SG11201901983PA SG11201901983PA SG11201901983PA SG11201901983PA SG11201901983PA SG 11201901983P A SG11201901983P A SG 11201901983PA SG 11201901983P A SG11201901983P A SG 11201901983PA SG 11201901983P A SG11201901983P A SG 11201901983PA SG 11201901983P A SG11201901983P A SG 11201901983PA
- Authority
- SG
- Singapore
- Prior art keywords
- basel
- roche
- group
- international
- grenzacherstrasse
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16187960 | 2016-09-09 | ||
| PCT/EP2017/072062 WO2018046428A1 (en) | 2016-09-09 | 2017-09-04 | Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrrole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201901983PA true SG11201901983PA (en) | 2019-04-29 |
Family
ID=56936288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201901983PA SG11201901983PA (en) | 2016-09-09 | 2017-09-04 | Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrrole |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11306093B2 (sl) |
| EP (1) | EP3510031B1 (sl) |
| JP (1) | JP6997769B2 (sl) |
| KR (1) | KR102502701B1 (sl) |
| CN (1) | CN109689653B (sl) |
| AR (1) | AR109586A1 (sl) |
| AU (1) | AU2017324297B2 (sl) |
| BR (1) | BR112019004091B1 (sl) |
| CA (1) | CA3035624A1 (sl) |
| ES (1) | ES2847903T3 (sl) |
| HR (1) | HRP20210145T1 (sl) |
| IL (1) | IL265013B (sl) |
| MX (1) | MX2019002362A (sl) |
| PL (1) | PL3510031T3 (sl) |
| SG (1) | SG11201901983PA (sl) |
| SI (1) | SI3510031T1 (sl) |
| TW (1) | TWI753009B (sl) |
| WO (1) | WO2018046428A1 (sl) |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR044152A1 (es) * | 2003-05-09 | 2005-08-24 | Bayer Corp | Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad |
| FR2876377B1 (fr) | 2004-10-11 | 2007-03-16 | Univ Claude Bernard Lyon | Nouveaux derives de 9h-pyrido[2,3-b]indole, leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes |
| CA2715390A1 (en) | 2008-02-14 | 2009-08-20 | Siemens Medical Solutions Usa, Inc. | Imaging agents for detecting neurological dysfunction |
| US8932557B2 (en) | 2008-02-14 | 2015-01-13 | Eli Lilly And Company | Imaging agents for detecting neurological dysfunction |
| CN102119162B (zh) | 2008-06-11 | 2014-10-08 | 健泰科生物技术公司 | 二氮杂咔唑及其使用方法 |
| EP2323697A2 (en) | 2008-07-24 | 2011-05-25 | Siemens Medical Solutions USA, Inc. | Imaging agents useful for identifying ad pathology |
| US20100056491A1 (en) * | 2008-08-29 | 2010-03-04 | Memory Pharmaceuticals Corporation | 4'-amino cyclic compounds having 5-ht6 receptor affinity |
| US8691187B2 (en) | 2009-03-23 | 2014-04-08 | Eli Lilly And Company | Imaging agents for detecting neurological disorders |
| US8491869B2 (en) | 2009-03-23 | 2013-07-23 | Eli Lilly And Company | Imaging agents for detecting neurological disorders |
| US20110183938A1 (en) | 2009-12-16 | 2011-07-28 | Genentech, Inc. | 1,7-diazacarbazoles and methods of use |
| US20150368244A1 (en) | 2011-01-31 | 2015-12-24 | Genentech, Inc. | Diazacarbazoles and methods of use |
| RU2014103806A (ru) | 2011-07-05 | 2015-08-10 | Вертекс Фармасьютикалз Инкорпорейтед | Способы и промежуточные соединения для получения азаиндолов |
| JP6034005B2 (ja) | 2011-08-03 | 2016-11-30 | 出光興産株式会社 | ビスカルバゾール誘導体およびこれを用いた有機エレクトロルミネッセンス素子 |
| KR101770531B1 (ko) * | 2013-10-08 | 2017-08-22 | 에프. 호프만-라 로슈 아게 | 타우-펫-리간드로서의 다이아자카르바졸 유도체 |
| BR112017016311A2 (pt) * | 2015-02-02 | 2018-03-27 | Ucb Biopharma Sprl | derivados de 9h-pirrolo-dipiridina |
| EP3347363B1 (en) * | 2015-09-09 | 2020-01-01 | H. Hoffnabb-La Roche Ag | N-(3-azabicyclo[3.2.1]octan-8-yl)-8-(4-phenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[l,5-a]pyridin-2-amine derivatives as gamma-secretase modulators for treating alzheimer's disease |
-
2017
- 2017-09-04 KR KR1020197008785A patent/KR102502701B1/ko active IP Right Grant
- 2017-09-04 PL PL17768700T patent/PL3510031T3/pl unknown
- 2017-09-04 CN CN201780054464.2A patent/CN109689653B/zh active Active
- 2017-09-04 CA CA3035624A patent/CA3035624A1/en active Pending
- 2017-09-04 ES ES17768700T patent/ES2847903T3/es active Active
- 2017-09-04 SG SG11201901983PA patent/SG11201901983PA/en unknown
- 2017-09-04 AU AU2017324297A patent/AU2017324297B2/en active Active
- 2017-09-04 JP JP2019513417A patent/JP6997769B2/ja active Active
- 2017-09-04 WO PCT/EP2017/072062 patent/WO2018046428A1/en unknown
- 2017-09-04 BR BR112019004091-9A patent/BR112019004091B1/pt active IP Right Grant
- 2017-09-04 SI SI201730610T patent/SI3510031T1/sl unknown
- 2017-09-04 EP EP17768700.1A patent/EP3510031B1/en active Active
- 2017-09-04 MX MX2019002362A patent/MX2019002362A/es active IP Right Grant
- 2017-09-08 AR ARP170102478A patent/AR109586A1/es active IP Right Grant
- 2017-09-08 TW TW106130720A patent/TWI753009B/zh active
-
2019
- 2019-02-24 IL IL265013A patent/IL265013B/en unknown
- 2019-03-06 US US16/294,627 patent/US11306093B2/en active Active
-
2021
- 2021-01-28 HR HRP20210145TT patent/HRP20210145T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112019004091B1 (pt) | 2023-02-14 |
| KR20190044648A (ko) | 2019-04-30 |
| JP2019529401A (ja) | 2019-10-17 |
| EP3510031A1 (en) | 2019-07-17 |
| KR102502701B1 (ko) | 2023-02-23 |
| AU2017324297A1 (en) | 2019-03-14 |
| TW201811787A (zh) | 2018-04-01 |
| TWI753009B (zh) | 2022-01-21 |
| AR109586A1 (es) | 2018-12-26 |
| EP3510031B1 (en) | 2020-12-02 |
| US11306093B2 (en) | 2022-04-19 |
| AU2017324297B2 (en) | 2021-08-05 |
| HRP20210145T1 (hr) | 2021-03-05 |
| CN109689653A (zh) | 2019-04-26 |
| BR112019004091A2 (pt) | 2019-05-28 |
| MX2019002362A (es) | 2019-06-17 |
| IL265013B (en) | 2021-09-30 |
| CN109689653B (zh) | 2022-04-12 |
| SI3510031T1 (sl) | 2021-03-31 |
| ES2847903T3 (es) | 2021-08-04 |
| PL3510031T3 (pl) | 2021-05-31 |
| JP6997769B2 (ja) | 2022-02-10 |
| WO2018046428A1 (en) | 2018-03-15 |
| CA3035624A1 (en) | 2018-03-15 |
| US20190300529A1 (en) | 2019-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201901700UA (en) | Biaryl compounds useful as immunomodulators | |
| SG11201810003UA (en) | Using programmable dna binding proteins to enhance targeted genome modification | |
| SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
| SG11201809913PA (en) | Methods for detecting target nucleic acids in a sample | |
| SG11201908640TA (en) | Pyrrolidinones and a process to prepare them | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201807426WA (en) | Immunomodulators | |
| SG11201805300QA (en) | Heterocyclic compounds as immunomodulators | |
| SG11201805709RA (en) | Anti-pro/latent myostatin antibodies and methods of use thereof | |
| SG11201909433XA (en) | Targeted compositions | |
| SG11201901834WA (en) | Micrornas as biomarkers for endometriosis | |
| SG11201804890TA (en) | Bipyrazolyl derivatives useful for the treatment of autoimmune diseases | |
| SG11201903582UA (en) | Settlement method, entrance control method, and apparatus | |
| SG11201804774YA (en) | Diastereoselective synthesis of phosphate derivatives and of the gemcitabine prodrug nuc-1031 | |
| SG11201805595TA (en) | Process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid | |
| SG11201805115PA (en) | Detection and quantification of target nucleic acid sequence of a microorganism | |
| SG11201906844RA (en) | Biometric feature database establishing method and apparatus | |
| SG11201907364WA (en) | Anti-tryptase antibodies, compositions thereof, and uses thereof | |
| SG11201807038UA (en) | Rodents having a humanized tmprss gene | |
| SG11202000333UA (en) | Bicyclic ketone compounds and methods of use thereof | |
| SG11201807382RA (en) | A single- or multiple component composition for producing a hydrogel | |
| SG11201807775SA (en) | Aqueous polymer dispersions, a method for their preparation and the use thereof as pour-point depressants for crude oil, petroleum, and petroleum products | |
| SG11201906807VA (en) | Compositions and methods for promoting hair growth with mpc1 inhibitors | |
| SG11201805263TA (en) | Compositions and methods for detecting and treating esophageal cancer | |
| SG11201807478QA (en) | Methods and compositions for increased double stranded rna production |